1-4 of 4
Katharine A. Whartenby
Close
Sort by
Journal Articles

Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR

Tianhong Wang, Qiong Jiang, Camie Chan, Kevin S. Gorski, Erin McCadden, David Kardian, Drew Pardoll, Katharine A. Whartenby
Journal: Blood
Blood (2009) 113 (13): 2906–2913.
https://doi.org/10.1182/blood-2008-08-176354
Published: 2009
Journal Articles

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss, Andrew S. Flies, Lijie Zhen, Rubin M. Tuder, Joseph F. Grosso, Timothy J. Harris, Derese Getnet, Katharine A. Whartenby, Dirk G. Brockstedt, Thomas W. Dubensky, Jr, Lieping Chen, Drew M. Pardoll, Charles G. Drake
Journal: Blood
Blood (2007) 110 (1): 186–192.
https://doi.org/10.1182/blood-2006-12-062422
Published: 2007
Journal Articles

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Sanju Jalla, PhD, Erin McCadden, Jie Wang, MD, Ephraim J. Fuchs, MD, Katharine A. Whartenby, PhD
Journal: Blood
Blood (2004) 104 (11): 3175.
https://doi.org/10.1182/blood.V104.11.3175.3175
Published: 2004
Journal Articles

Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation

Katharine A. Whartenby, Erin E. Straley, Heeje Kim, Frederick Racke, Vivek Tanavde, Kevin S. Gorski, Linzhao Cheng, Drew M. Pardoll, Curt I. Civin
Journal: Blood
Blood (2002) 100 (9): 3147–3154.
https://doi.org/10.1182/blood-2002-01-0118
Published: 2002